Adempas (riociguat), an approved therapy for adults with PH, may hold promise for treating newborns with bronchopulmonary dysplasia (BPD) and the PH it can cause, research in an animal model of both diseases shows; doctors have resisted its use because of fears of bone growth problems.
Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.